MARISSA CASILLO: Open Payments
NPI 1972251817 · FOXBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,113 in 219 payments from 38 companies in 2025. Trend: 2023 $4,010 · 2024 $3,785 · 2025 $22,113
Speaker / faculty: $15,206Food & beverage: $5,104Travel & lodging: $1,128Consulting: $675
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 22 | $8,835 |
| PFIZER INC. | 22 | $6,446 |
| ABBVIE INC. | 26 | $3,219 |
| EMD Serono, Inc. | 43 | $1,041 |
| Lundbeck LLC | 17 | $600 |
| SK Life Science, Inc. | 10 | $300 |
| Eisai Inc. | 8 | $186 |
| Biogen, Inc. | 8 | $172 |
| Amgen Inc. | 8 | $135 |
| Mallinckrodt Hospital Products Inc. | 5 | $111 |
Products named: BRIUMVI, NURTEC ODT, QULIPTA, UBRELVY, VYEPTI, Leqembi, TYSABRI, UPLIZNA.
Industry payments across MA — which companies pay providers there.
